Trial Profile
Phase 2 open-label study of MIV-210 in antiretroviral treatment experienced HIV-1 infected subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2019
Price :
$35
*
At a glance
- Drugs Lagociclovir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Medivir AB
- 09 Aug 2019 Status changed from not stated to completed.
- 09 Sep 2013 Status changed from completed to unconfirmed.
- 31 Oct 2005 New trial record.